High Wall Avenue analysts modified their outlook on these high names. For a whole view of all analyst ranking modifications, together with upgrades, downgrades and initiations, please see our analyst scores web page.
- William Blair analyst Matt Phipps initiated protection on Climb Bio Inc (NASDAQ:CLYM) with an Outperform ranking. Climb Bio shares closed at $1.94 on Wednesday. See how different analysts view this inventory.
- Baird analyst Peter Arment initiated protection on Rocket Lab Corp (NASDAQ:RKLB) with an Outperform ranking and introduced a value goal of $83. Rocket Lab shares closed at $69.27 on Wednesday. See how different analysts view this inventory.
- B of A Securities analyst Dina Ramadane initiated protection on Vera Therapeutics Inc (NASDAQ:VERA) with a Purchase ranking and introduced a value goal of $48. Vera Therapeutics shares closed at $31.00 on Wednesday. See how different analysts view this inventory.
- Chardan Capital analyst Daniil Gataulin initiated protection on Opus Genetics Inc (NASDAQ:IRD) with a Purchase ranking and introduced a value goal of $9. Opus Genetics closed at $2.00 on Wednesday. See how different analysts view this inventory.
- Goldman Sachs analyst Michael Ng initiated protection on Celestica Inc (NYSE:CLS) with a Purchase ranking and introduced a value goal of $340. Celestica shares closed at $269.96 on Wednesday. See how different analysts view this inventory.
Contemplating shopping for CLS inventory? Right here’s what analysts assume:
Learn This Subsequent:
Photograph through Shutterstock
Market Information and Information delivered to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.
